Abcam’s aim is to serve life science researchers to achieve their mission, faster. We continuously listen, collaborate and support the scientific community in order to improve and offer new affinity binders, reagents, biomarkers and assays that will drive greater scientific progress. Our culture is a key differentiator. We believe in empowering individuals, with responsibility given at an early stage. The working environment is fun and fast-paced, collaborative and outcome focused, with a strong customer focus. In addition to competitive salaries we offer an attractive flexible benefits package with plenty of opportunities to learn and grow. Our head office is in Cambridge (UK), we also have offices in Bristol (UK), Cambridge, Eugene and San Francisco (USA), Tokyo (Japan), Hong Kong, Hangzhou and Shanghai (China). We have a range of roles in IT background and would normally look for candidates with a degree in computer science or other numerate disciplines. We also recruit positions for candidates with a scientific background and we would normally look for candidates with biological science qualifications.
Type
Public
HQ
Milton, GB
Founded
1998
Size (employees)
882 (est)+13%
Website
abcam.com
Abcam was founded in 1998 and is headquartered in Milton, GB
Report incorrect company information

Key People/Management at Abcam

Jonathan Milner

Jonathan Milner

CEO

Abcam Office Locations

Abcam has an office in Hangzhou, Burlingame, Cambridge, Chuo and in 8 other locations
Cambridge, US (HQ)
b2304 One Kendall Square Binney St
Milton, GB (HQ)
330 Cambridge Science Park Milton Rd
Cambridge, US
b2304 1 Kendall Square
Shanghai, CN
Galileo Rd. Pudong
Tokyo, JP
2-2-1 Nihonbashi Horidome-cho
Show all (13)
Report incorrect company information

Abcam Financials and Metrics

Abcam Financials

Abcam's revenue was reported to be £217.10 m in FY, 2017
GBP

Revenue (FY, 2017)

217.1 m

Gross profit (FY, 2017)

152.1 m

Gross profit margin (FY, 2017), %

70.1%

Net income (FY, 2017)

42.4 m

EBITDA (FY, 2017)

70.5 m

EBIT (FY, 2017)

55.1 m

Market capitalization (2-Oct-2017)

2 b

Closing share price (2-Oct-2017)

9.8

Cash (2-Feb-2018)

84.8 m
Abcam's current market capitalization is £2 b.
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

36.7 m56.8 m71.1 m83.3 m97.8 m122.2 m128 m144 m171.7 m217.1 m

Revenue growth, %

13%19%

Cost of goods sold

14.4 m19.4 m23.7 m27.2 m30.3 m35.5 m37.6 m42.5 m51.1 m65 m

Gross profit

22.3 m37.4 m47.4 m56 m67.6 m86.7 m90.4 m101.5 m120.5 m152.1 m
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

5.9 m12.3 m19.2 m23.8 m25.4 m32.7 m34 m37.4 m37.4 m42.4 m

Cash From Operating Activities

7.1 m14.8 m19.7 m25.5 m24.5 m39.4 m41.3 m40.2 m47.3 m66.4 m

Dividends Paid

2.6 m5.3 m7.9 m10.1 m12.5 m11.3 m15.9 m16.7 m19.1 m

Cash From Financing Activities

(2.2 m)(1.2 m)(27.4 m)(7.6 m)10.7 m(11.8 m)(13.8 m)(14.1 m)(15.4 m)(17.7 m)
GBPY, 2017

Revenue/Employee

246.1 k

Financial Leverage

1.2 x
Show all financial metrics
Report incorrect company information